Condition
Old Myocardial Infarction
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
4Total
P 1 (2)
P 2 (2)
Trial Status
Terminated2
Unknown2
Clinical Trials (4)
Showing 4 of 4 trials
NCT03351400Phase 1Unknown
Japanese OMI Treatment With Kit-positive Cells for Enhanced Regeneration
NCT00908622Phase 2TerminatedPrimary
Study of the Efficacy of Percutaneous Implantation of Autologous Myoblasts in Patients With Old Infarction
NCT00975234Phase 2TerminatedPrimary
Treatment With Autologous Skeletal Myoblasts
NCT01267331Phase 1UnknownPrimary
Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery
Showing all 4 trials